Increased extracellular dopamine concentrations and FosB/ΔFosB expression in striatal brain areas of heterozygous GDNF knockout mice

European Journal of Neuroscience

Volumn 20, Issue 9, 2004, Pages 2336-2344

  Airavaara, Mikko ^a   Planken, Anu ^b   Gäddnäs, Helena ^a   Piepponen, Timo Petteri ^a   Saarma, Mart ^b   Ahtee, Liisa ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Cocaine; FosB immunohistochemistry; Glial cell line derived neurotrophic factor; Microdialysis

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 5 HYDROXYINDOLEACETIC ACID; DOPAMINE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; HOMOVANILLIC ACID; PROTEIN FOS; TRANSCRIPTION FACTOR FOSB; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DOPAMINERGIC NERVE CELL; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; MICRODIALYSIS; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL;

AFFERENT PATHWAYS; ANIMALS; COCAINE; CORPUS STRIATUM; DOPAMINE; DOPAMINE AGONISTS; EXTRACELLULAR FLUID; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICRODIALYSIS; MOTOR ACTIVITY; NERVE GROWTH FACTORS; NEURONS; NUCLEUS ACCUMBENS; PRESYNAPTIC TERMINALS; PROTO-ONCOGENE PROTEINS C-FOS; SUBSTANTIA NIGRA; SYNAPTIC TRANSMISSION; UP-REGULATION;

EID: 8144227885     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2004.03700.x     Document Type: Article

References (40)

1. Airaksinen, M.S. & Saarma, M. (2002) The GDNF family: signalling, biological functions and therapeutic value. Nature Rev. Neurosci., 3, 383-394.
2. Andersson, M., Westin, J.E. & Cenci, M.A. (2003) Time course of striatal DeltaFosB-like immunoreactivity and prodynorphin mRNA levels after discontinuation of chronic dopaminomimetic treatment. Eur. J. Neurosci., 17. 661-666.
3. Beck, K.D., Irwin, I., Valverde, J., Brennan, T.J., Langston, J.W. & Hefti, F. (1996) GDNF induces a dystonia-like state in neonatal rats and stimulates dopamine and serotonin synthesis. Neuron, 16, 665-673.
4. Beck, K.D., Valverde, J., Alexi, T., Poulsen, K., Moffat, B., Vandlen, R.A., Rosenthal, A. & Hefti, F. (1995) Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature, 373, 339-341.
5. Berretta, S., Robertson, H.A. & Graybiel, A.M. (1992) Dopamine and glutamate agonists stimulate neuron-specific expression of Fos-like protein in the striatum. J. Neurophysiol., 68, 767-777.
6. Bourque, M.J. & Trudeau, L.E. (2000) GDNF enhances the synaptic efficacy of dopaminergic neurons in culture. Eur. J. Neurosci., 12, 3172-3180.
7. Castaneda, E., Whishaw, I.Q. & Robinson, T.E. (1990) Changes in striatal dopamine neurotransmission assessed with microdialysis following recovery from a bilateral 6-OHDA lesion: variation as a function of lesion size. J. Neurosci., 10, 1847-1854.
8. Chen, J., Kelz, M.B., Hope, B.T., Nakabeppu, Y. & Nestler, E.J. (1997) Chronic Fos-related antigens: stable variants of deltaFosB induced in brain by chronic treatments. J. Neurosci., 17, 4933-4941.
9. Chen, J., Nye, H.E., Kelz, M.B., Hiroi, N., Nakabeppu, Y., Hope, B.T. & Nestler, E.J. (1995) Regulation of delta FosB and FosB-like proteins by electro-convulsive seizure and cocaine treatments. Mol. Pharmacol., 48, 880-889.
10. Feng, L., Wang, C.Y., Jiang, H., Oho, C., Mizuno, K., Dugich-Djordjevic, M. & Lu, B. (1999) Differential effects of GDNF and BDNF on cultured ventral mesencephalic neurons. Brain Res. Mol. Brain Res., 66, 62-70.
11. Franklin, K.B.J. & Paxinos, G. (1997) The Mouse Brain in Stereotaxic Coordinates. Academic Press, San Diego.
12. Gerlai, R., McNamara, A., Choi-Lundberg, D.L., Armanini, M., Ross, J., Powell-Braxton, L. & Phillips, H.S. (2001) Impaired water maze learning performance without altered dopaminergic function in mice heterozygous for the GDNF mutation. Eur. J. Neurosci., 14, 1153-1163.
13. Giros, B., Jaber, M., Jones, S.R., Wightman, R.M. & Caron, M.G. (1996) Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature, 379, 606-612.
14. Granholm, A.C., Reyland, M., Albeck, D., Sanders, L., Gerhardt, G., Hoernig, G., Shen, L., Westphal, H. & Hoffer, B. (2000) Glial cell line-derived neurotrophic factor is essential for postnatal survival of midbrain dopamine neurons. J. Neurosci., 20, 3182-3190.
15. Granholm, A.C., Srivastava, N., Mott, J.L., Henry, S., Henry, M., Westphal, H., Pichel, J.G., Shen, L. & Hoffer, B.J. (1997) Morphological alterations in the peripheral and central nervous systems of mice lacking glial cell line-derived neurotrophic factor (GDNF): immunohistochemical studies. J. Neurosci., 17, 1168-1178.
16. Green-Sadan, T., Kinor, N., Roth-Deri, I., Geffen-Aricha, R., Schindler, C.J. & Yadid, G. (2003) Transplantation of glial cell line-derived neurotrophic factor-expressing cells into the striatum and nucleus accumbens attenuates acquisition of cocaine self-administration in rats. Eur. J. Neurosci., 18, 2093-2098.
17. Griffin, W.C., Boger, H., Saylor, A., Bohrer, B. & Middaugh, L.D. (2003) Partial deletion of GDNF in female mice: Effects on cocaine-related behaviors and sucrose self-administration. Soc. Neurosci. Abstr., on line. [Program No. 879.1 2003 Abstract Viewer/Itinerary Planner, Society for Neuroscience, On Line, Washington, DC.]
18. Hebert, M.A., Van Horne, C.G., Hoffer, B.J. & Gerhardt, G.A. (1996) Functional effects of GDNF in normal rat striatum: presynaptic studies using in vivo electrochemistry and microdialysis. J. Pharmacol. Exp. Ther., 279, 1181-1190.
19. Hoffer, B.J., Huffman, A., Bowenkamp, K., Huettl, P., Hudson, J., Martin, D., Lin, L.F. & Gerhardt, G.A. (1994) Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo. Neurosci. Lett., 182, 107-111.
20. Hope, B.T., Kelz, M.B., Duman, R.S. & Nestler, E.J. (1994a) Chronic electroconvulsive seizure (ECS) treatment results in expression of a long-lasting AP-1 complex in brain with altered composition and characteristics. J. Neurosci., 14, 4318-4328.
21. Hope, B.T., Nye, H.E., Kelz, M.B., Self, D.W., Iadarola, M.J., Nakabeppu, Y., Duman, R.S. & Nestler, E.J. (1994b) Induction of a long-lasting AP-1 complex composed of altered Fos-like proteins in brain by chronic cocaine and other chronic treatments. Neuron, 13, 1235-1244.
22. Hurd, Y.L., Kehr, J. & Ungerstedt, U. (1988) In vivo microdialysis as a technique to monitor drug transport: correlation of extracellular cocaine levels and dopamine overflow in the rat brain. J. Neurochem., 51, 1314-1316.
23. Jones, S.R., Gainetdinov, R.R., Wightman, R.M. & Caron, M.G. (1998) Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter. J. Neurosci., 18, 1979-1986.
24. Kalivas, P.W. & Stewart, J. (1991) Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res. Brain Res. Rev., 16, 223-244.
25. Lin, L.F., Doherty, D.H., Lile, J.D., Bektesh, S. & Collins, F. (1993) GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science, 260, 1130-1132.
26. Messer, C.J., Eisch, A.J., Carlezon, W.A. Jr, Whisler, K., Shen, L., Wolf, D.H., Westphal, H., Collins, F., Russell, D.S. & Nestler, E.J. (2000) Role for GDNF in biochemical and behavioral adaptations to drugs of abuse. Neuron, 26, 247-257.
27. Moore, M.W., Klein, R.D., Farinas, I., Sauer, H., Armanini, M., Phillips, H., Reichardt, L.F., Ryan, A.M., Carver-Moore, K. & Rosenthal, A. (1996) Renal and neuronal abnormalities in mice lacking GDNF. Nature, 382, 76-79.
28. Nestler, E.J., Barrot, M. & Self, D.W. (2001) DeltaFosB; a sustained molecular switch for addiction. Proc. Natl Acad. Sci. USA, 98, 11042-11046.
29. Nye, H.E., Hope, B.T., Kelz, M.B., Iadarola, M. & Nestler, E.J. (1995) Pharmacological studies of the regulation of chronic FOS-related antigen induction by cocaine in the striatum and nucleus accumbens. J. Pharmacol. Exp. Ther., 275, 1671-1680.
30. Nye, H.E. & Nestler, E.J. (1996) Induction of chronic Fos-related antigens in rat brain by chronic morphine administration. Mol. Pharmacol., 49, 636-645.
31. Ohta, K., Kuno, S., Mizuta, I., Fujinami, A., Matsui, H. & Ohta, M. (2003) Effects of dopamine agonists bromocriptine, pergolide, cabergoline, and SKF-38393 on GDNF, NGF, and BDNF synthesis in cultured mouse astrocytes. Life Sci., 73, 617-626.
32. Ohta, M., Mizuta, I., Ohta, K., Nishimura, M., Mizuta, E., Hayashi, K. & Kuno, S. (2000) Apomorphine up-regulates NGF and GDNF synthesis in cultured mouse astrocytes. Biochem. Biophys. Res. Commun., 272, 18-22.
33. Pennypacker, K.R., Hong, J.S. & McMillian, M.K. (1995) Implications of prolonged expression of Fos-related antigens. TIPS, 16, 317-321.
34. Pichel, J.G., Shen, L., Sheng, H.Z., Granholm, A.C., Drago, J., Grinberg, A., Lee, E.J., Huang, S.P., Saarma, M., Hoffer, B.J., Sariola, H. & Westphal, H. (1996) Defects in enteric innervation and kidney development in mice lacking GDNF. Nature, 382, 73-76.
35. Pothos, E.N., Davila, V. & Sulzer, D. (1998) Presynaptic recording of quanta from midbrain dopamine neurons and modulation of the quantal size. J. Nuerosci., 18, 4106-4118.
36. Robinson, T.E. & Berridge, K.C. (2003) Addiction. Annu. Rev. Psychol., 54, 25-53.
37. Sanchez, M.P., Silos-Santiago, I., Frisen, J., He, B., Lira, S.A. & Barbacid, M. (1996) Renal agenesis and the absence of enteric neurons in mice lacking GDNF. Nature, 382, 70-73.
38. Tomac, A., Lindqvist, E., Lin, L.F., Ogren, S.O., Young, D., Hoffer, B.J. & Olson, L. (1995) Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature, 373, 335-339.
39. Xu, K. & Dluzen, D.E. (2000) The effect of GDNF on nigrostriatal dopaminergic function in response to a two-pulse K(+) stimulation. Exp. Neurol., 166, 450-457.
40. Zhang, D., Zhang, L., Lou, D.W., Nakabeppu, Y., Zhang, J. & Xu, M. (2002) The dopamine D1 receptor is a critical mediator for cocaine-induced gene expression. J. Neurochem., 82, 1453-1464